You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Latin American consensus on guidelines for chronic migraine treatment
|
|---|---|
| Published in |
Arquivos de Neuro-Psiquiatria, July 2013
|
| DOI | 10.1590/0004-282x20130066 |
| Pubmed ID | |
| Authors |
Alex Rodrigo Espinoza Giacomozzi, Alexander Parajeles Vindas, Ariovaldo Alberto da Silva, Carlos Alberto Bordini, Carlos Federico Buonanotte, Célia Aparecida de Paula Roesler, Cláudio Manoel Brito, Cristina Perez, Deusvenir de Souza Carvalho, Djacir Dantas Pereira de Macedo, Elcio Juliato Piovesan, Machado Sarmento, Eliana Meire Melhado, Fabíola Dach Éckeli, Fernando Kowacs, Fidel Sobrino, Getúlio Daré Rabello, Grisel Rada, Jano Alves de Souza, Juana Rosa Casanovas, Juan Carlos Durán, Leandro Cotoni Calia, Luis Roberto Partida Medina, Luiz Paulo de Queiroz, Marcelo Cedrinho Ciciarelli, Marcelo Moraes Valença, Maria Cusicanqui, Maria Karina Velez Jimenez, Maria Tereza Goycochea, Mário Fernando Prieto Peres, Mario Victor Fuentealba Sandoval, Maurice Borges Vincent, Michel Volcy Gomes, Mónica Diez, Nayeska Aranaga, Nelson Barrientos, Pedro André Kowacs, Pedro Ferreira Moreira Filho |
| Abstract |
Chronic migraine is a condition with significant prevalence all around the world and high socioeconomic impact, and its handling has been challenging neurologists. Developments for understanding its mechanisms and associated conditions, as well as that of new therapies, have been quick and important, a fact which has motivated the Latin American and Brazilian Headache Societies to prepare the present consensus. The treatment of chronic migraine should always be preceded by a careful diagnosis review; the detection of possible worsening factors and associated conditions; the stratification of seriousness/impossibility to treat; and monitoring establishment, with a pain diary. The present consensus deals with pharmacological and nonpharmacological forms of treatment to be used in chronic migraine. |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 2% |
| Unknown | 87 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 14 | 16% |
| Other | 11 | 12% |
| Researcher | 11 | 12% |
| Student > Postgraduate | 10 | 11% |
| Student > Master | 8 | 9% |
| Other | 17 | 19% |
| Unknown | 18 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Nursing and Health Professions | 4 | 4% |
| Neuroscience | 4 | 4% |
| Other | 9 | 10% |
| Unknown | 24 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2013.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Arquivos de Neuro-Psiquiatria
#1,141
of 1,369 outputs
Outputs of similar age
#183,614
of 206,704 outputs
Outputs of similar age from Arquivos de Neuro-Psiquiatria
#15
of 18 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,369 research outputs from this source. They receive a mean Attention Score of 4.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,704 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.